2'H-PREGNA-2,4-DIENO(3,2-C)PYRAZOL-20-ONE, 11,17,21-TRIHYDROXY-2'-(2-HYDROXYETHYL)-16-METHYL-, (11.BETA.,16.ALPHA.)-
UNII 4SZJ987Y99
Substance Identification & Data
This profile provides standardized clinical and technical data for 2'h-pregna-2,4-dieno(3,2-c)pyrazol-20-one, 11,17,21-trihydroxy-2'-(2-hydroxyethyl)-16-methyl-, (11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4SZJ987Y99.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 55038-88-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H36N2O5 FMWRTAPDANMWFK-UTXXINLTSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2'h-pregna-2,4-dieno(3,2-c)pyrazol-20-one, 11,17,21-trihydroxy-2'-(2-hydroxyethyl)-16-methyl-, (11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.